Skip to main content
. 2022 Jul 29;13:928593. doi: 10.3389/fimmu.2022.928593

Figure 6.

Figure 6

miR-144/451-/- DCs-transplantation exacerbates DSS-induced mice colitis. CD45.1+ WT recipient mouse was treated with 2.5% DSS, and adoptively transferred with WT (CD45.2+, n=6) or miR-144/451 KO (CD45.2+, n=6) DCs via tail vein at day -1, day 3 and day 5. Changes in body weight (A). Disease activity index of colitis (B). Morphology of colons (C), and bars represent the length of colons (D). Frequency of CD45.2+ cells in spleen and MLN of recipient mice (E). Expression of CD80, CD86 and IL-6 on CD45.2+ DCs from spleen (F, G) and MLN (H, I) of colitis mice. Ns. no significance, *p<0.05, **p<0.01, ***p<0.001.